RxDoctor Payments Data

Elizabeth Powell

Family · Slidell, LANPI 1528776028

Payments from drug & device makers

$2,146in general payments, 2019–2025

Across 85 payments — averaging $25.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$366
  • AbbVie$273
  • Amgen$224
  • Corcept Therapeutics$215
  • Lilly USA, LLC$153
  • AstraZeneca$125
  • plus $791 from 16 others

What the payments were for

  • Food & beverage$2,146100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,146 in reported general payments places this provider in the 75th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide46$48,677
OzempicSemaglutide34$34,207
MounjaroTirzepatide24$26,820
KerendiaFinerenone18$18,019
EliquisApixaban19$17,864
JardianceEmpagliflozin16$14,730
Spiriva HandihalerTiotropium Bromide29$14,612
SymbicortBudesonide/Formoterol Fumarate38$8,926
Spiriva RespimatTiotropium Bromide11$5,809
Albuterol Sulfate HfaAlbuterol Sulfate104$2,714
Humalog Kwikpen U-100Insulin Lispro14$2,221
Gabapentin121$1,562
Duloxetine Hcl39$985
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$922
Atorvastatin Calcium130$859

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$153$75,49770 claims
Novo NordiskOzempic$31$34,20734 claims
BayerKerendia$105$18,01918 claims
PfizerEliquis$17$17,86419 claims
AstraZenecaSymbicort$125$8,92638 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,610 family providers in Louisiana.

Other family in Slidell

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →